MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • 2025 International Congress

    Prevalence and Management of Depression Among Parkinson’s Patient’s in an Outpatient Clinic Setting

    E. Parker, T. Siriwardena (Perth, Australia)

    Objective: To evaluate the prevalence of depression among Parkinson’s Disease (PD) patients attending an outpatient clinic and review current management to improve diagnosis and treatment…
  • 2025 International Congress

    The Role of Sex in Cognitive Impairment, Depression, Anxiety, Hallucinations, Disease Severity and Sleep Disorder Symptoms in Parkinson’s Disease: A Mexican Cohort Study

    A. Fierro-Ruiz, A. Solari-Capra, A. Steven-Garcia, P. Reyes-Perez, A. Lázaro-Figueroa, E. Morelos Figaredo, C. Guerra-Galicia, I. Estrada-Bellmann, K. Salinas-Barboza, Y. Matuk-Pérez, N. Gandarilla-Martínez, U. Caballero-Sánchez, P. Montes-Alcantara, V. Flores-Ocampo, I. Espinoza-Mendez, A. Zayas-Del-Mora, E. Gaspar-Martinez, E. Waldo, T. Leal, M. Inca-Martinez, I. Mata, S. Alcauter, A. Medina-Rivera, A. Ruiz-Contreras (Querétaro, Mexico)

    Objective: To examine sex differences in non-motor symptoms such as cognitive impairment, depression, anxiety, hallucinations, disease severity (Hoehn & Yahr scale), and sleep disorders in…
  • 2025 International Congress

    Effect of Systematic Survey-based Screening for Depression in Parkinson’s Disease

    M. Super, D. Potts, C. Marshall, N. Dahodwala (Philadelphia, USA)

    Objective: To determine the impact of systematic survey-based screening for depression on treatment outcomes in people with Parkinson's disease (PD) in a clinical practice setting. Background: Depression in…
  • 2025 International Congress

    Prevalence of urinary problems in men and women with Parkinson’s disease. A study from the Mexican Parkinson’s Research Network.

    A. Garcia, A. Fierro, A. Solari, P. Reyes, A. Lazaro, E. Morelos, C. Guerra, I. Estrada, K. Salinas, Y. Matuk, N. Gandarilla, U. Caballero, P. Montés, V. Flores, I. Espinosa, A. Hayas, E. Gaspar, D. Vazquez, M. Rodriguez, E. Waldo, T. Leal, M. Inca, I. Mata, S. Alcauter, M. Renteria, A. Medina, A. Ruiz (CDMX, Mexico)

    Objective: To analyze whether there is a relationship between sex and the presence of genitourinary symptoms in patients with Parkinson’s disease and its impact on…
  • 2025 International Congress

    Whispers of Hope Motor and Psychiatric Recovery in Fahr’s Disease with High-Frequency rTMS: A Case Report

    D. Ortiz-Zacarias, JA. Sánchez Garza, S. Luna Garza, N. Gutierrez Canales, V. Medina Mier, S. Castillo-Torres, IE. Estrada-Bellman (Monterrey, Mexico)

    Objective: To present a case of FD showing significant motor and psychiatric improvement following high-frequency rTMS of the DLPFC Background: Fahr’s disease (FD) is a…
  • 2025 International Congress

    Cerebral Vasoreactivity and Neuropsychiatric Features in Parkinson’s disease.

    M. Cansino Torres, D. Ortiz Zacarias, S. Castillo Torres, R. Lopez Soto, J. Trejo Ayala, A. Infante Valenzuela, F. Gongora Rivera, B. Chavez Luevanos, I. Estrada Bellmann (Monterrey, Mexico)

    Objective: To determine cerebral vasoreactivity (CVR) in Parkinson’s disease (PD) and its association with the neuropsychiatric features of the disease. Background: Non-motor symptoms in PD…
  • 2025 International Congress

    Progression of Motor & Non-motor symptoms of Parkinson’s Disease with Prior History of Head Trauma

    C. Kastoun, R. Rajmohan, J. Ruiz Tejeda, N. Phielipp (Orange, USA)

    Objective: We compared the progression of motor (M) and nonmotor (NM) symptoms in subjects with Parkinson’s Disease (PD) with pre-existing head trauma (HT), with or…
  • 2025 International Congress

    Alterations in Basal Ganglia Synaptic Density and Thalamic Gray Matter Volume are associated with Motor Signs in Late Life Depression: an 11C-UCB-J PET/MR study.

    M. van Cauwenberge, T. Vande Casteele, M. Laroy, K. Vansteelandt, K. van Laere, J. Vanden Stock, F. Bouckaert, L. Emsell, M. Vandenbulcke (Leuven, Belgium)

    Objective: To investigate differences in the association of motor signs with synaptic density, gray matter volume and white matter lesion volume in patients with late…
  • 2025 International Congress

    Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson’s Disease – A Randomized, Placebo-Controlled Trial (Short Title: ProD)

    A. Lemkow, A. Kuan, J. Lam, F. Vila-Rodriguez, M. Mckeown, J. Squires, A. Howard, S. Appel-Cresswell (Vancouver, Canada)

    Objective: Objective: To assess the impact of probiotic supplementation on depression symptoms and the gut microbiome in people living with Parkinson’s disease (PwPD). Background: Background:…
  • 2025 International Congress

    Impact of manganese exposure on neurobehavioral disorders in rats: Insights into oxidative stress pathways and Parkinsonian syndrome pathophysiology

    H. Harifi, H. Hami, L. Bikjdaouene (Kenitra, Morocco)

    Objective: This study investigates the correlation between oxidative stress in various neural structures induced by manganese (Mn) and the onset of anxious and depressive behaviours…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley